FDA Expects Sharp Drop In Drug Applications This Year
This article was originally published in The Pink Sheet Daily
Executive Summary
Announcing the PDUFA fees for fiscal 2011, agency says it expects to receive 117.5 fee-paying full application equivalents in the current fiscal year, down 16 percent from the 2009 level.
You may also be interested in...
FDA Sees Another Submission Decrease In FY 2011, Increases Application Fees
The figures continue a recent trend of decreases in fee-paying full application equivalents but were not as low as had been estimated.
FDA Sees Another Submission Decrease In FY 2011, Increases Application Fees
The figures continue a recent trend of decreases in fee-paying full application equivalents but were not as low as had been estimated.
NDA, BLA Submissions Expected To Fall Again in FY 2011
FDA estimates that the number of fee-paying applications will continue to decline, meaning the user fee itself will increase more than 19% to $1.842 million for applications requiring clinical data.